These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26606873)

  • 1. Masked hypertension and its associated cardiovascular risk in young individuals: the African-PREDICT study.
    Thompson JE; Smith W; Ware LJ; M C Mels C; van Rooyen JM; Huisman HW; Malan L; Malan NT; Lammertyn L; Schutte AE
    Hypertens Res; 2016 Mar; 39(3):158-65. PubMed ID: 26606873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Masked hypertension in renal transplant recipients.
    Kayrak M; Gul EE; Kaya C; Solak Y; Turkmen K; Yazici R; Guney I; Altintepe L; Turk S; Ozdemir K
    Blood Press; 2014 Feb; 23(1):47-53. PubMed ID: 23721572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes.
    Lithovius R; Gordin D; Forsblom C; Saraheimo M; Harjutsalo V; Groop PH;
    Diabetologia; 2018 Sep; 61(9):1935-1945. PubMed ID: 29797021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing Masked Hypertension Using Ambulatory Blood Pressure Monitoring, Home Blood Pressure Monitoring, or Both?
    Anstey DE; Muntner P; Bello NA; Pugliese DN; Yano Y; Kronish IM; Reynolds K; Schwartz JE; Shimbo D
    Hypertension; 2018 Nov; 72(5):1200-1207. PubMed ID: 30354812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Masked Hypertension in Low-Income South African Adults.
    Ware LJ; Rennie KL; Gafane LF; Nell TM; Thompson JE; Van Rooyen JM; Schutte R; Schutte AE
    J Clin Hypertens (Greenwich); 2016 May; 18(5):396-404. PubMed ID: 26762489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension.
    Andrikou I; Tsioufis C; Dimitriadis K; Syrseloudis D; Valenti P; Almiroudi M; Lioni L; Tousoulis D; Stefanadis C
    Blood Press Monit; 2011 Oct; 16(5):218-23. PubMed ID: 21914984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot study.
    Takeno K; Mita T; Nakayama S; Goto H; Komiya K; Abe H; Ikeda F; Shimizu T; Kanazawa A; Hirose T; Kawamori R; Watada H
    Am J Hypertens; 2012 Feb; 25(2):165-70. PubMed ID: 22089111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between exercise capacity and masked hypertension in sedentary patients with diabetes mellitus.
    Akilli H; Kayrak M; Arıbas A; Tekinalp M; Ayhan SS; Gündüz M; Alibasic H; Altunbas G; Yazıcı M
    Clin Exp Hypertens; 2014; 36(1):9-16. PubMed ID: 23734826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Masked hypertension in obesity: potential predictors and arterial damage.
    Kenny IE; Saeed S; Gerdts E; Midtbø H; Halland H; Lønnebakken MT
    Blood Press Monit; 2017 Feb; 22(1):12-17. PubMed ID: 27776078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Masked Hypertension Among US Adults With Nonelevated Clinic Blood Pressure.
    Wang YC; Shimbo D; Muntner P; Moran AE; Krakoff LR; Schwartz JE
    Am J Epidemiol; 2017 Feb; 185(3):194-202. PubMed ID: 28100465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
    Fukuhara M; Arima H; Ninomiya T; Hata J; Hirakawa Y; Doi Y; Yonemoto K; Mukai N; Nagata M; Ikeda F; Matsumura K; Kitazono T; Kiyohara Y
    Stroke; 2013 Jun; 44(6):1512-7. PubMed ID: 23640825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of masked hypertension and associated factors in normotensive healthcare workers.
    Sobrino J; Domenech M; Camafort M; Vinyoles E; Coca A;
    Blood Press Monit; 2013 Dec; 18(6):326-31. PubMed ID: 24192846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.
    Tang H; Gong WY; Zhang QZ; Zhang J; Ye ZC; Peng H; Wang C; Lou T
    Nephrology (Carlton); 2016 Oct; 21(10):841-50. PubMed ID: 26566951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Masked Hypertension and Obesity in Renal Transplant Recipients.
    Sasak G; Ecder SA
    Transplant Proc; 2019 Sep; 51(7):2355-2357. PubMed ID: 31402245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and covariates of masked hypertension in ischemic stroke survivors: the Norwegian Stroke in the Young Study.
    Saeed S; Waje-Andreassen U; Fromm A; Øygarden H; Naess H; Gerdts E
    Blood Press Monit; 2016 Aug; 21(4):244-50. PubMed ID: 27093704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of demographic, clinical, and laboratory parameters between patients with sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension.
    Afsar B
    J Cardiol; 2013 Mar; 61(3):222-6. PubMed ID: 23294898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtypes of masked hypertension and target organ damage in untreated outpatients.
    Zhang DY; Cheng YB; Guo QH; Wang Y; Sheng CS; Huang QF; An DW; Li MX; Huang JF; Xu TY; Wang JG; Li Y
    Blood Press; 2020 Oct; 29(5):299-307. PubMed ID: 32400191
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of spironolactone on vascular, myocardial, and functional parameters in untreated patients with a hypertensive response to exercise.
    Hare JL; Sharman JE; Leano R; Jenkins C; Wright L; Marwick TH
    Am J Hypertens; 2013 May; 26(5):691-9. PubMed ID: 23412930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Masked hypertension, rather than white-coat hypertension, has a prognostic role in patients with non-dialysis chronic kidney disease.
    Wang C; Zhang J; Li Y; Ma X; Ye Z; Peng H; Lou T
    Int J Cardiol; 2017 Mar; 230():33-39. PubMed ID: 28034462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.